Inside Scope
By American Gastroenterological Association (AGA)
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 58
Description
Welcome to Inside Scope, the American Gastroenterological Association podcast that will help you advance your patient care, one half-hour segment at a time. Join us to hear from the experts, learn new skills, and stay abreast of changing best practices in gastroenterology patient care.
| Episode | Date |
|---|---|
|
HE: Missed diagnosis of cirrhosis in the inpatient setting
|
May 21, 2025 |
|
HE: Strategies to prevent readmission from inadequate transitions of care
|
May 21, 2025 |
|
HE: Specific challenges in geriatric cirrhosis and HE
|
May 21, 2025 |
|
HE: Changing epidemiology of cirrhosis and hepatic encephalopathy
|
May 21, 2025 |
|
HE: Current and emerging treatment modalities
|
May 21, 2025 |
|
HE: Inadequate practices in the inpatient setting
|
May 21, 2025 |
|
EoE: Why I-SEE Matters and Evidence To-Date
|
Feb 18, 2025 |
|
EoE: Picking the Right Tool For the Job
|
Feb 18, 2025 |
|
Clinical Practice Update: Endoscopic approach to recurrent acute and chronic pancreatitis
|
Nov 19, 2024 |
|
Clinical Practice Update: Alpha-gal syndrome for the GI clinician
|
Nov 19, 2024 |
|
Clinical Practice Update: Diagnosis and management of cyclic vomiting syndrome
|
Nov 19, 2024 |
|
Clinical Practice Update: Diet and nutritional therapies for IBD
|
Nov 19, 2024 |
|
Clinical Practice Updates: Help your patients with nonalcoholic fatty liver disease (NAFLD) lose weight
|
Nov 19, 2024 |
|
Hepatorenal syndrome–acute kidney injury: Pathophysiology
|
Apr 02, 2024 |
|
Hepatorenal syndrome–acute kidney injury: Liver transplantation
|
Apr 02, 2024 |
|
Hepatorenal syndrome–acute kidney injury: Diagnosis and non-pharmacological management
|
Apr 02, 2024 |
|
Hepatorenal syndrome–acute kidney injury: Current pharmacologic therapies
|
Apr 02, 2024 |
|
Gastro Grand Rounds: Drug-induced liver injury
|
Mar 12, 2024 |
|
Diversity in IBD Trials: Start with our workforce
|
Dec 27, 2023 |
|
Diversity in IBD Trials: Changing how we talk to patients
|
Dec 27, 2023 |
|
Diversity in IBD Trials: The role of the CRO
|
Dec 27, 2023 |
|
Diversity in IBD Trials: Bringing research to the community
|
Dec 27, 2023 |
|
Diversity in IBD Trials: The community GI’s perspective
|
Dec 27, 2023 |
|
Diversity in IBD Trials: How Artificial Intelligence May Help
|
Dec 27, 2023 |
|
Gastro Grand Rounds: Perianal Crohn’s disease
|
Dec 18, 2023 |
|
Gastro Grand Rounds: Managing diverticulitis
|
Nov 13, 2023 |
|
C. diff: FMT and new microbiome therapies
|
Sep 19, 2023 |
|
C. diff: Impact of rCDI on patients and their lives
|
Aug 29, 2023 |
|
C. diff: Case management and transitions of care
|
Aug 29, 2023 |
|
C. diff: Reconciling guideline differences for testing and treatment
|
Aug 29, 2023 |
|
C. diff: Microbiota changes
|
Aug 29, 2023 |
|
C. diff: Risk factors
|
Aug 29, 2023 |
|
Innovation in Duodenoscope Design: Opportunities with single-use scopes beyond infection control
|
Apr 25, 2023 |
|
Innovation in Duodenoscope Design: FDA’s approach to post-market surveillance
|
Apr 25, 2023 |
|
Innovation in Duodenoscope Design: Are disposable scopes the answer?
|
Apr 25, 2023 |
|
Innovation in Duodenoscope Design: Making sense of endoscope reprocessing guidelines
|
Apr 25, 2023 |
|
Biosimilars: Managing switch scenarios with biologics and biosimilars
|
Dec 16, 2022 |
|
Biosimilars: Communicating with a patient who does not want to switch
|
Dec 16, 2022 |
|
Biosimilars: The logistics of switching between biosimilars or between biosimilars and reference product
|
Dec 16, 2022 |
|
Biosimilars: Starting a patient on biologic therapy
|
Dec 12, 2022 |
|
Colorectal cancer: Getting paid: Updated information about coverage, cost-sharing, reimbursement, coding
|
Oct 03, 2022 |
|
Colorectal cancer: Eliminating screening barriers for high-risk populations
|
Oct 03, 2022 |
|
Colorectal cancer: Managing high-risk populations in primary care
|
Oct 03, 2022 |
|
Colorectal cancer: Working with your 45-49 patients on colorectal cancer screening
|
Oct 03, 2022 |
|
Colorectal cancer: What you need to know now — the USPSTF guidelines
|
Oct 03, 2022 |
|
Obesity in GI Care: Coverage and Reimbursement
|
Jun 14, 2022 |
|
Obesity in GI Care: Evaluating outcomes, adapting treatment plans and the future
|
Jun 07, 2022 |
|
Obesity in GI Care: Updates on devices
|
May 31, 2022 |
|
Obesity in GI Care: Updates on medications
|
May 25, 2022 |
|
Obesity in GI Care: Diet options
|
May 10, 2022 |
|
Obesity in GI Care: How I embraced it and why you should too
|
Mar 31, 2022 |
|
NASH: Working together
|
Jan 10, 2022 |
|
NASH: Management strategies
|
Jan 10, 2022 |
|
NASH: Diagnosing NAFLD and NASH
|
Jan 10, 2022 |
|
NASH: Screening in the primary care setting
|
Jan 10, 2022 |
|
NASH: Metabolic syndrome
|
Jan 10, 2022 |
|
NASH: The burden
|
Jan 10, 2022 |
|
Trailer: NASH: Take Action!
|
Jan 07, 2022 |